Literature DB >> 30394344

Comparison of rectal misoprostol's effect when used before and after a cesarean section on post-cesarean bleeding.

Azam Sharafi1, Marzieh Ghasemi2.   

Abstract

OBJECTIVE: Cesarean section is a common surgery in women. Different drugs are used to control its bleeding. This study compared the effect of using rectal misoprostol before and after surgery on the amount of post-cesarean bleeding.
MATERIALS AND METHODS: A number of 120 women who were admitted to our hospital because of elective cesarean section entered this clinical trial. They were divided into two groups. The first (before surgery) group received 400μg of rectal misoprostol before the cesarean section and the second (after surgery) group after the surgery. The amount of bleeding was measured in both groups. The data were recorded and analyzed.
RESULTS: Their mean of age was 29.1±6.1 years old. The mean of blood loss volume was 283±147mL in the before-surgery group and 294±108mL in the after-surgery group (P=0.6). There was no significant difference in the level of post-operation hemoglobin between the two groups. However, the frequency of need for additional uterotonics was 47% in the first group and 85% in the second group (P<0.001).
CONCLUSION: There seems to be no significant difference in administering rectal misoprostol before or after the surgery, but the need for additional uterotonics is reduced if it is used before the surgery.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Before surgery; Bleeding; Cesarean section; Hemorrhage; Misoprostol

Mesh:

Substances:

Year:  2018        PMID: 30394344     DOI: 10.1016/j.jogoh.2018.10.017

Source DB:  PubMed          Journal:  J Gynecol Obstet Hum Reprod        ISSN: 2468-7847


  2 in total

1.  Grade Prediction of Bleeding Volume in Cesarean Section of Patients With Pernicious Placenta Previa Based on Deep Learning.

Authors:  Jun Liu; Tao Wu; Yun Peng; Rongguang Luo
Journal:  Front Bioeng Biotechnol       Date:  2020-04-30

2.  Rectal vs. sublingual misoprostol in cesarean section: Three‑arm, randomized clinical trial.

Authors:  Fatemeh Zahra Bagheri; Mahboobeh Azadehrah; Bizhan Shabankhani; Ebrahim Nasiri Formi; Hooshang Akbari
Journal:  Caspian J Intern Med       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.